Evidence map›Paper›PMID 32456165›Full record

ReviewCancers2020

A Bird's-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers.

Benjamin Motais, Sandra Charvátová, Matouš Hrdinka, Michal Šimíček, Tomáš Jelínek, Tereza Ševčíková, Zdeněk Kořístek, Roman Hájek, Juli R Bagó

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Benjamin MotaisFaculty of Medicine, University of Ostrava, Ostrava 703 00, Czech Republic.
Sandra CharvátováFaculty of Medicine, University of Ostrava, Ostrava 703 00, Czech Republic.
Matouš HrdinkaFaculty of Medicine, University of Ostrava, Ostrava 703 00, Czech Republic.
Michal ŠimíčekFaculty of Medicine, University of Ostrava, Ostrava 703 00, Czech Republic.
Tomáš JelínekFaculty of Medicine, University of Ostrava, Ostrava 703 00, Czech Republic.
Tereza ŠevčíkováFaculty of Medicine, University of Ostrava, Ostrava 703 00, Czech Republic.
Zdeněk KořístekFaculty of Medicine, University of Ostrava, Ostrava 703 00, Czech Republic.
Roman HájekFaculty of Medicine, University of Ostrava, Ostrava 703 00, Czech Republic.
Juli R BagóFaculty of Medicine, University of Ostrava, Ostrava 703 00, Czech Republic.
University of Ostrava · CZ

Funding

Cell Coolab Ostrava - Research and Development Center for Cell Therapy in Hematology and Oncology No. CZ.02.1.01/0.0/0.0/17_049/0008440Institutional Development Plan of University of Ostrava, allocated by The Ministry of Education, Youth and Sports project no. IRP03_2018-2020New Directions of Biomedical Research in the Ostrava Region No. CZ.02.1.01/0.0/0.0/18_069/0010060
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

blood cancerCAR-T cellscell-based therapydendritic cellsiPSCmacrophagesNK cellsplateletsstem cells

Identifiers

PMID32456165
PMCPMC7281611
OpenAlexW3028402584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.